Showing results (211-220 of 294) with videos related to
Sort By:
Pageof 30
L'Encephale|November 14, 2006
[Health related quality of life and lipodystrophy syndrome among HIV-infected patients]M Préau, A-D Bouhnik, B Spire, et al.Clinical Pharmacology and Therapeutics|July 3, 1999
Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudineC Michelet, E Bellissant, A Ruffault, et al.Antimicrobial Agents and Chemotherapy|November 16, 2001
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patientsC Michelet, A Ruffault, V Sébille, et al.Journal of Virological Methods|October 19, 2017
Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapyC Allavena, A Rodallec, A Leplat, et al.Medecine Et Maladies Infectieuses|April 7, 2009
[Epidemiology of candidemia: a one-year prospective observational study in the west of France]J-P Talarmin, D Boutoille, P Tattevin, et al.Journal of Obesity|June 22, 2012
Associations between Overall and Abdominal Obesity and Suicidal Ideation among US Adult WomenGuixiang Zhao, Chaoyang Li, Earl S Ford, et al.Sexually Transmitted Infections|October 19, 2021
Risk factors for HIV infection among men who have sex with men in the ANRS IPERGAY PrEP trialJulien Gras, Marine Pillet, Guillemette Antoni, et al.Antiviral Therapy|July 19, 2005
Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patientsV Reliquet, V Ferré, C Hascoet, et al.Open Heart|June 11, 2024
Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil studyAline Pedroso Camargos, Sandhi Barreto, Luisa Brant, et al.The Journal of Antimicrobial Chemotherapy|May 28, 2016
Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combinationS Lambert-Niclot, C Allavena, M Grude, et al.Pageof 30